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Health-related quality of life (HRQoL) is an essential complementary parameter in the
assessment of disease burden and treatment outcome in multiple sclerosis (MS) and can
be affected by neuropsychiatric symptoms, which in turn are sensitive to psychological
stress. However, until now, the impact of neurobiological stress and relaxation on HRQoL
in MS has not been investigated. We thus evaluated whether the activity of neural
networks triggered by mild psychological stress (elicited in an fMRI task comprising
mental arithmetic with feedback) or by stress termination (i.e., relaxation) at baseline
(T0) predicts HRQoL variations occurring between T0 and a follow-up visit (T1) in 28
patients using a robust regression and permutation testing. The median delay between
T0 and T1 was 902 (range: 363–1,169) days. We assessed HRQoL based on the
Hamburg Quality of Life Questionnaire in MS (HAQUAMS) and accounted for the impact
of established HRQoL predictors and the cognitive performance of the participants.
Relaxation-triggered activity of a widespread neural network predicted future variations
in overall HRQoL (t = 3.68, pfamily−wise error [FWE]-corrected = 0.008). Complementary
analyses showed that relaxation-triggered activity of the same network at baseline
was associated with variations in the HAQUAMS mood subscale on an αFWE = 0.1
level (t = 3.37, pFWE = 0.087). Finally, stress-induced activity of a prefronto-limbic
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network predicted future variations in the HAQUAMS lower limb mobility subscale
(t = −3.62, pFWE = 0.020). Functional neural network measures of psychological
stress and relaxation contain prognostic information for future HRQoL evolution in MS
independent of clinical predictors.
Keywords: multiple sclerosis, quality of life, neuropsychiatric symptoms, psychological stress, functional magnet
resonance imaging (fMRI)
INTRODUCTION
Multiple sclerosis (MS) is a chronic autoimmune disease of the
central nervous system driven by inflammation, demyelination,
and neurodegeneration (1). While sensorimotor and visual
symptoms have long been considered the major disease burden
of MS, it is now widely accepted that they reflect just one of
the several groups of debilitating symptoms (2, 3). Additional
symptoms comprise cognitive impairment (4, 5), fatigue (6), and
neuropsychiatric symptoms, such as depression and anxiety (7),
which together contribute to a reduced quality of life (QoL).
In line with this broad range of contributing factors, QoL is a
multidimensional concept that is defined as a person’s subjective
overall well-being and ability to participate in and enjoy life
according to individual goals and expectations (8, 9). More
specifically, the term health-related QoL (HRQoL) refers to QoL
of an individual affected by health problems, medical conditions,
and their treatments (10). Consistently, HRQoL is understood as
an important complementary parameter in the assessment of MS
symptoms, which otherwise may be overlooked, and a relevant
patient-reported outcome for treatment success [e.g., (2, 11)].
Today, only few prognostic markers exist for MS symptom
progression in general and HRQoL in particular. Male sex
and younger age at onset are the only clinico-demographic
factors influencing the progression to severe disability (12).
Furthermore, MS studies on psychobiological stress found that
(i) exposure to mild and extreme stress is associated with an
increased risk for MS relapses and disease exacerbation (13, 14),
(ii) participation in stress management interventions can reduce
the formation of new MRI lesions (15) and (iii) hypothalamo–
pituitary–adrenal (HPA) axis hyperactivity is associated with
future disability accrual (16, 17). Finally, predictors of future
HRQoL evolution were identified as disease duration and clinical
disability (18).
Interestingly, we recently showed that neural processing of
stressful stimuli is a predictor for future MS disease severity (19),
whereas others found that psychobiological stress contributes
significantly to depressive symptoms in persons without MS (20,
21). In line with this finding, Fu et al. (22) showed that individual
variations in neurocognitive aversive picture processing can be
used to predict the future outcome of depression treatment
in persons with major depressive disorder (without MS).
Thus, given the close links between stress processing and
neuropsychiatric symptoms such as depression on one hand
(20–22) and their connection to HRQoL on the other (23),
we investigated whether neural activity variations identified in
an fMRI stress task can predict the future course of HRQoL
in Persons with MS (PwMS). Specifically, we conducted an
established fMRI stress task (24, 25) employing mild to moderate
stressors (mental arithmetic with social evaluation) to measure
neural processes associated with exposure to and cessation of
stress at baseline (T0) in 28 PwMS. Conforming with current
definitions of psychological relaxation as a process that reduces
stress [e.g., (26)], we treated activity variations occurring after
stress cessation as neural measures of relaxation. Additionally,
we measured pulse and perceived stress levels. We then used
the neural markers measured to predict the evolution of HRQoL
assessed with the Hamburg Quality of Life Questionnaire in MS
[HAQUAMS; (27)] between T0 and a follow-up visit (T1; median
delay 902 days). We hypothesized that neural network activity




This longitudinal study comprising two time points (T0 and T1)
is an extension of a study investigating neural stress processing
in PwMS and healthy controls at a single time point [i.e., at
T0; (28)]. Patients with MS investigated in this recent study
were recruited by the Clinical Neuroimmunology Group in the
NeuroCure Clinical Research Center (NCRC) in cooperation
with the Charité neuroimmunology outpatient clinic. All T0
data of the present longitudinal study was taken from 28 PwMS
who participated in a work by Weygandt et al. (28), and for
whom HAQUAMS and clinical disability data (gathered in
ongoing clinical cohort studies conducted by the NCRC Clinical
Neuroimmunology Group) were available for T1. PwMS were
included in T0 (i) when diagnosed with relapsing-remitting
MS (RRMS) or secondary-progressive (SPMS) MS according
to McDonald Criteria 2010 (29), (ii) in case of stable disease-
modifying treatment (DMT) for at least 6 months or stable
disease without DMT, (iii) when aged ≥ 18 years, and (iv)
when physically and mentally capable to use the test devices
without restrictions. Candidate participants were excluded when
pregnant or when diagnosed with a mental or addictive disorder,
neurologic diseases other than MS, acute MS relapses, or acute
infections. The exclusion criteria for T1 were the same as for T0
and inclusion criteria (ii) and (iii) were applied in T1. All studies
were approved by the research ethics committee of the Charité
– Universitätsmedizin Berlin, and written informed consent was
obtained from all participants at T0 and T1 according to the
Declaration of Helsinki.
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FIGURE 1 | Stress task (for details see “Methods and Materials”). The task consisted of seven stages (I–VII). Neural activity and pulse signals were measured during
the first baseline stage (II), the stress stage (IV), and the second baseline stage (VI). The stress stage comprised multiple-choice arithmetic subtraction tasks each
followed by feedback depending on individual performance of the participant. During the first part of this stage, the performance level of the participant was assessed
(adaption stage) which served as the foundation for the participant’s individual level of difficulty for the subsequent performance part of the stress stage. During
baseline stages, participants were asked to focus on a fixation cross on the MRI screen. During the prebaseline stage (I), prestress stage (III), poststress stage (V), and
postbaseline stage (VII), participants were asked to rate the degree of perceived psychological stress. The figure was adapted from Meyer-Arndt et al. (19).
Structural MRI and task-derived rating data on perceived
stress for T0 and HRQoL data (T0 & T1) were available for all
28 patients (23 RRMS, five SPMS). FMRI data (T0) for two of
the three fMRI stages (“Baseline 1” and “Stress”; see below) were
available for all 28 participants, and for 27 for the third stage
(“Baseline 2”). Pulse data were consistently available across all
three fMRI stages for a subset of 21 participants. It is noted that
fMRI, structural MRI, pulse, and rating data acquired at T0 were
also evaluated in Refs. (19, 28), and T0HAQUAMS data were also
evaluated in Refs. (30, 31).
Clinical Assessment
Experienced neurologists examined all patients at T0 and T1
using the Expanded Disability Status Scale [EDSS; (32)]. We
used the HAQUAMS [Version 3.2, (27)] as an MS-specific,
self-report assessment tool for evaluation of overall HRQoL
and five (sub-)scales (fatigue [4 items], lower limb mobility
[5 items], upper limb mobility [5 items], social functions
[6 items], mood-related symptoms [8 items]) at T0 and T1.
Compared to other MS-specific HRQoL questionnaires, the
HAQUAMS offers the advantage to be both comprehensive
including psychosocial factors and disease-specific symptoms as
well as feasible regarding completion duration. The total score
for overall HRQoL is calculated as the mean across subscales.
Patients were neither asked to give their own global rating for
QoL nor were they invited to add items other than those listed
in the assessment tool used as we aspired to a high degree of
comparability between patients. Low scores in each of the five
subscales and the total score indicate a high HRQoL. Moreover,
the difference in parameters for longitudinal HRQoL variations
was computed for each scale (HRQoL at T1 – HRQoL at T0).
Experimental Stress Paradigm
We applied a version of an established arterial-spin-labeling
(ASL) fMRI stress task which was derived from Wang et al.
(25) as well as Kirschbaum et al. (33), which was also used
in Weygandt et al. (28), and which included mental arithmetic
tasks and immediate performance feedback (Figure 1). This task
comprised seven consecutive stages (I–VII). During four of these
stages (I. prebaseline 1, III. prestress, V. poststress, and VII.
postbaseline 2), participants were asked to rate the degree of
perceived psychological stress on a nine-point scale, which was
displayed on a projection screen inside the MRI scanner using
MRI-compatible button tools. The leftmost point corresponded
to the option “gar nicht” (German for “not at all”), whereas the
rightmost point represented the option “sehr stark” (German for
“very strong”). Functional brain activity was acquired using ASL
fMRI during the three remaining stages (II. baseline 1; 8min
duration, IV. stress; 12min, and VI. baseline 2; 8min). During
stages II, IV, and VI, pulse signals were acquired using an MRI-
compatible pulse oximeter (refer to Supplement Methods and
Materials for details on pulse rate assessment). During baseline
1 and 2, participants were requested to focus on a fixation
cross. During the stress stage, participants were asked to perform
subtraction tasks (i.e., “operand X minus operand Y”) for which
they were to choose the correct result from four options displayed
underneath the arithmetical task. The start value for X was set
at 43,521 for all participants, whereas operand Y was randomly
selected in each trial and ranged from 1 to 99. The stress stage
was divided into two parts, an adaptation stage (IVa; ≤ 4-min
duration) and a performance stage (IVb; lasting for the remaining
time of this block). During the adaption stage, participants were
given 8 s per trial to choose a result option. Response times were
recorded. In case of a correct result, the difference X minus Y
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was used as operand X in the next trial. Otherwise, operand X
remained the same as in the previous trial. As soon as 10 correct
answers were achieved or 4min had passed, the performance
stage began without announcement. The performance stage was
different in three aspects. First, the time provided for each trial
was adjusted to a given participant’s arithmetic performance
(starting at 8 s and subsequently decreased or increased by
10% depending on response correctness). Second, feedback was
provided in the form of school grades ranging from “1 – sehr
gut” (German for “very good”) to “5 – ungenügend” (German
for “insufficient”) depending on performance. Finally, X was
reset to 43,521 in case of false or too slow answers. Prior to
the start of the MRI session, we informed the participants that
feedback would relate their output to performance measures
established in the general population. After the experiment, we
clarified that feedback was actually generated by relating their
performance in a given trial in the performance stage to that in
the adaptation stage.
Brain Imaging
As described in Weygandt et al. (28), brain scans at T0 were
acquired using a 3 Tesla whole-body tomograph (Magnetom
Trio, Siemens, Erlangen, Germany) and a 12-channel head coil.
Specifically, fMRI scans were assessed with a pseudo-continuous
ASL EPI sequence (25) which roughly covered the whole
brain (22 ascending transversal slices, slice thickness 5.75mm
[including 15% inter-slice gap]; in-plane voxel resolution 3 · 3
mm2; TR = 4,000ms; TE = 19ms; FA = 90◦; FOV = 192 ·
192 mm2; matrix size = 64 · 64; label duration 1.5 s, postlabel
delay 1.2 s; phase-encoding direction anterior to posterior). We
acquired 120 images (60 control and 60 labels) during baseline
1 and 2 (8-min duration) and 180 scans (90 control, 90 labels)
during the stress stage (12 min duration).
Furthermore, two spin-echo EPI reference volumes with
opposite phase encoding directions (anterior to posterior,
posterior to anterior) were assessed in advance to all three
experimental fMRI stages with identical parameters as reported
above for a distortion correction of ASL scans described
below. We assessed anatomical T1-weighted sequences using the
following parameters: 176 slices; slice thickness 1.3mm; in-plane
voxel resolution 1.5 · 1.5 mm2; TR = 1,720ms; TE = 2.34ms;
FA = 9◦; FOV = 192 · 192 mm2; matrix size = 128 × 128;
1min and 43 s duration. Additionally, a T2-weighted sequence
was acquired with these parameters:176 slices; 1mm isotropic
voxels; TR= 5,000ms; TE= 502ms; FA= 120◦; FOV= 256 · 256
mm2; matrix size= 256 · 256; 5min and 52 s duration. We opted
to use ASL fMRI due to its high sensitivity and its robustness
toward slow signal artifacts potentially mimicking stress-induced
signal changes and thus impairing proper preprocessing as
compared to other functional imaging techniques such as blood-
oxygen-level-dependent fMRI (25). We assessed anatomical T1-
weighted sequences using the following parameters: 176 slices;
slice thickness 1.3mm; in-plane voxel resolution 1.5 · 1.5 mm2;
TR = 1,720ms; TE = 2.34ms; FA = 9◦; FOV = 192 · 192 mm2;
matrix size = 128 × 128; 1min and 43 s duration. Additionally,
a T2-weighted sequence was acquired with these parameters:176
slices; 1mm isotropic voxels; TR= 5,000ms; TE= 502ms; FA=




Preprocessing of anatomical images comprised of three steps:
a manual lesion mapping procedure based on anatomical T2-
weighted images, segmentation of brain regions into areas of
homogenous tissue based on T1-weighted images, and finally
generation of a GM group mask for the predictive fMRI analyses
based on segmented images and lesion masks.
Lesion Mapping
Experienced raters manually generated patient-specific voxel
masks containing focal lesions using the OsiriX software
toolbox (OsiriX Foundation) based on T2-weighted images. The
procedure was supervised by a neuroradiologist.
Segmentation of T1-Weighted Anatomical Images
We used the combined spatial normalization and segmentation
SPM12 algorithm to segment the brain of each participant
into areas of gray matter (GM), white matter (WM), and
cerebrospinal fluid (CSF) and thus to determine voxel images
assessing the probability of each coordinate to belong to each
of the three tissues based on T1-weighted images. Coordinates
highlighted by themanually determined lesionmaps coregistered
to the T1-weighted images prior to the segmentation step were
excluded. Probability maps of GM, WM, and CSF were once
computed in the participant-specific (“native”) image space
and once in the anatomical standard space defined by the
Montreal Neurological Institute [MNI; (34)]. Maps determined
in the standard space were adjusted for spatial deformations
applied during the normalization. These maps are referred to as
“modulated” tissue maps in the following.
Computation of a GM Group Mask
In addition to lesion masking and segmentation, we determined
a group mask for GM in MNI-space, which was derived from
the modulated tissue probability maps of PwMS to constrain
our fMRI analyses to functional brain activity signals from GM
not affected by lesions as revealed by the procedure described
above. Specifically, using the modulated tissue maps, we first
determined the voxel-wise average modulated tissue probability
for GM, WM, and CSF across all patients. In a second step,
we assigned each voxel to the tissue class for which the mean
was maximal.
In a third step, we excluded coordinates from the mask
containing hyperintense lesions in at least one patient as denoted
by the co-registered, patient-specific lesion maps. In Order to
account for potential partial voluming effects, we additionally
removed the six direct neighbor voxels of each lesion voxels,
i.e., coordinates within the Euclidean distance of exactly one
voxel to a given lesion coordinate. Finally, we entered voxel
coordinates located in the mask and covered by all fMRI scans
of all participants into the predictive fMRI analysis.
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Functional Images
In the present study, we analyzed fMRI data, which were also
analyzed in Weygandt et al. (28). In the latter study, seven
preprocessing steps were applied. In the present study, data
resulting from the first to sixth step were entered into the group
analysis, step seven was omitted due to a network-wise approach
in the present study (instead of the voxel-wise analysis conducted
in Weygandt et al. (28)). Step (ii) was conducted using the
FSL Topup algorithm (35), (v) was conducted using the ASLtbx
toolbox for SPM12 [Wellcome Trust Centre for Neuroimaging,
Institute of Neurology, UCL, London UK - http://www.fil.ion.
ucl.ac.uk/spm; (36)]. All other steps were performed using
SPM12. Specifically, in step (i) we conducted a coregistration
of perfusion fMRI scans to spin-echo EPI volumes to facilitate
a distortion correction of functional scans. In step (ii) the
distortion correction/B0-unwarping was performed using both
spin-echo EPI reference images with opposing phase encoding
direction. In (iii) the functional images were coregistered to the
T1-weighted images. Moreover, in step (iv) functional scans were
spatially smoothed, in (v) voxel maps were determined reflecting
the average cerebral blood flow (CBF; ml/100 g/min) across the
full 8min of both baseline stages and the final 8min of the
stress stage based on control-label pairs. It is noted that only
the final 8min of the stress stage were used for computation
of neural stress parameters to guarantee equal feedback settings
across participants (which may have varied due to individual
performance differences or durations of the adaptation stage,
respectively, in case of utilizing the full 12min). In the last step
(vi), we used the coregistration parameters determined in the
segmentation of T1-weighted scans tomap the average CBFmaps
of the three fMRI conditions to the anatomical standard space
defined by the MNI (34). The spatially normalized CBF maps
(voxel size of 3 · 3 · 3 mm3) resulting from the preprocessing
procedure and determined for each participant and all three fMRI
conditions separately entered the fMRI group analysis.
Statistical Analyses
Psychophysiological Responses to Stress and
Relaxation
To test the effect of stress exposure and its cessation on perceived
stress and pulse, we performed linear mixed model (LMM)
analyses [e.g., (37)] implemented in Matlab 2014a (MathWorks,
Natick, Massachusetts, USA). Specifically, we tested whether
stress exposure is accompanied by an increase in perceived
stress (stages V vs. III) and pulse (IV vs. II). Moreover, we
evaluated whether cessation of stress is accompanied by a
reduction of perceived stress (VII vs. V) and pulse (VI vs.
IV). The fixed regressor of interest coded zeros (ones) for the
earlier (later) stage. In each analysis, MS type of participants
(RRMS or SPMS), cognitive task load (an inverse measure
of cognitive performance of participants; see Supplementary
analysis: “Association between cognitive task load and cognitive
performance”), sex, and age (plus intercept) were included in
the model as fixed covariates of no interest (CNI) to control
for interindividual variability. Finally, an intercept capturing
the average stress parameter of each participant across both
time points served as random CNI. The false positive rate was
evaluated with a permutation strategy for designs with repeated
measures [(38); 10,000 permutations]. For analyses of stress
exposure, we report parameters with a significant increase, for
effects of stress cessation outcomes with a significant decrease
(α = 0.05).
Longitudinal Variations of HRQoL
To evaluate longitudinal variations of overall HRQoL and
HAQUAMS subscales, we also employed LMM. Specifically, a
regressor of time coding 0 for T0 and the number of days for the
time delay between T0 and T1 for T1 served as a fixed covariate of
interest. Participants’ sex, age, MS type (RRMS or SPMS), and an
intercept served as fixed CNI. Additionally, a random intercept
was included. Again, permutation testing was used for inference
[(38); 10,000 permutations]. We report HRQoL parameters with
significant worsening across time at the group level according
to a threshold of α = 0.05. In the Supplement, we additionally
investigated whether longitudinal variations in (subscales of)
HRQoL were accompanied by similar EDSS variations. It is noted
that the linear relationships amongHAQUAMS (sub-)scales were
computed in the Supplement to yield additional insights into the
characteristics of the HRQoL measure in our sample.
Predicting Future HRQoL Based on
Clinico-Demographic and Radiographic Markers
In this analysis, we tested whether clinico-demographic and
radiographic markers assessed at T0 could predict future overall
HRQoL. This analysis served two purposes. First, we aimed
at testing whether future overall HRQoL could be predicted
based on clinico-demographic and radiographic parameters
identified as predictors in recent clinical studies [e.g., (18,
39)]. Second, significant clinico-demographic and radiographic
markers identified in this analysis were used as additional CNI
in the key analysis of the present work described in section
Predicting Future HRQoL Based on Neurocognitive Stress and
Relaxation Processing. “Predicting future HRQoL based on
neurocognitive stress and relaxation processing.”
Specifically, inspired by findings of Baumstarck et al. (18) and
Yalachkov et al. (39), we tested the prognostic information of
nine clinico-demographic and radiographic markers for future
overall HRQoL (i.e., the difference in the total HAQUAMS
scores for T1 minus T0) in nine separate robust regression
analyses (one for each marker). The nine markers evaluated
were: sex, age, education, clinical disability, the annualized
relapse rate, T2-weighted lesion load, MS type (RRMS or SPMS),
disease duration, and overall GM fraction of participants. Robust
regression was used due to its statistical power and reduced
sensitivity to outliers compared to traditional ordinary least
square regression (40–42). Total HAQUAMS scores at T0 and
the duration of the interval between T0 and T1 in days (plus
constant) were entered in each of the nine analyses as CNI. A
robust permutation method proposed by DiCiccio and Romano
(41) relying on the Chi2-distributed Wald-statistic was used to
compute the false positive rate (10,000 permutations in each
analysis). Parameters were considered significant predictors of
longitudinal HRQoL if the false positive rate determined for
two-sided effects α was <0.05.
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Predicting Future HRQoL Based on Neurocognitive
Stress and Relaxation Processing
In this analysis, we investigated whether activity changes of
neural networks triggered by stress exposure or by its cessation
predict the future evolution of HRQoL. We applied a technique
named principal component regression [e.g., (43)], which
combines two methods widely used in neuroimaging research,
i.e., principal component analysis [PCA; (44, 45)] and linear
regression (46). The analysis is comprised of three major steps.
In the first, we identified neural networks composed of areas
whose activity was strongly characterized by the activity of a given
network during the stress stage. Specifically, we first determined
the average voxel CBF of each participant and each GM region
included in the Neuromorphometrics neuroanatomical atlas
(http://Neuromorphometrics.com) for each fMRI stage (i.e.,
covering the full 8min of both baseline stages and the final
8min of the fMRI stress stage) individually. Next, we centered
regional mean CBF signals of the participants by subtracting their
average overall GM CBF (i.e., the average computed across all
average GM region CBF signals) for each fMRI stage individually.
Subsequently, we employed PCA to determine a small number
of hidden or latent variables (i.e., principal components; PCs)
based on the centered regional GM CBF signal of the fMRI
stress stage [compare e.g., (47) on the use of averaged regional
fMRI signals in functional network studies]. The PCs (which
are similar to “factors” in factor analyses of questionnaire data)
reflect the shared characteristic variation underlying the signals
of individual regions contributing to a given network during the
stress stage across participants. Each individual PC represents
one network and encodes the network activity of a participant in
terms of a single number. The number of PCs is predetermined
by the input data and corresponded to 28 (i.e., the number of
participants) in this study.
In the second step, we computed differential network activity
parameters reflecting the effect of stress exposure and its
cessation. Specifically, we first used the centered regional activity
signals of both baseline stages to determine the activity of
the network during these stages. Afterward, we subtracted the
network activity scores for baseline 1 from those for stress (stress
exposure) and the activity scores for stress from those for baseline
2 (cessation of stress). Refer to the Supplement for further
information (including on the “Winner-Takes-All” method used
to determine which brain regions are related to which networks).
In the third step, we used the differential network activity
parameters to predict the longitudinal evolution of overall
HRQoL with robust regression. This was done for each neural
process type (i.e., stress exposure or cessation of stress), and
each of the 28 networks. Complementary analyses tested these
associations for all five HAQUAMS subscales. To account for
the potential impact of confounding variables, we included
generic nuisance factors in the robust regression model (to
address basic longitudinal modeling or cognitive neuroscience
aspects) as well the disease-specific variable(s) identified in
preparatory analysis 2.6.3 (to address for clinico-demographic
aspects). Given that only disease type (SPMS vs. RRMS) but
none of the other eight markers including education and clinical
disability was significantly associated with future overall HRQoL
variations according to the analysis described in 2.6.3 (see
Results section Predicting Future HRQoL Based on Clinic-
Demographic and Radiographic Markers), we included three
generic CNI (follow-up period duration per participant in
days, T0-HAQUAMS scores in a given scale, and cognitive
task load) and one disease-specific (disease type). It is noted
that this sequential analysis scheme (i.e., identification of
significant clinico-demographic or neuroradiographic variables
in preparatory analysis, section Predicting Future HRQoL
Based on Clinico-Demographic and Radiographic Markers,
and inclusion of identified significant predictor variables in
key analysis, section Predicting Future HRQoL Based on
Neurocognitive Stress and Relaxation Processing) was applied
to avoid an unnecessary reduction in statistical power which
would have followed from including all nine (mostly HRQoL-
unrelated) clinico-demographic or neuroradiographic variables.
We deployed the same robust permutation method proposed
by DiCiccio et al. (41) as in the previous analysis. For the
key outcome markers (future variation in overall HRQoL), we
report significant associations according tomultiple comparisons
or FWE corrected threshold for two-sided effects of αFWE =
0.05, which was computed with the Bonferroni method (i.e.,
by dividing the false positive rate of a single test [α = 0.05]
by the number of PCs [N = 28]). Within this framework, the
uncorrected equivalent of αFWE = 0.05 was αuncorrected = 0.0018.
For the complementary (i.e., subscale) analyses, we applied a
threshold of αFWE = 0.1. The uncorrected equivalent of αFWE =
0.1 was αuncorrected = 0.0036.
RESULTS
Demographic and Clinical Participant
Characteristics
A total of 28 PwMS (23 RRMS, five SPMS) participated in this
study. Eighteen participants were women and 18 participants
obtained at least a high school diploma. The median age at T0
was 49 years (range: 27–61) and at T1 51 years (range: 29–64).
The median disease duration (since the first manifestation) at
T0 was 3,491 days (range: 271–12,250). Moreover, the median
EDSS was 3.5 (range: 1–6) at T0 and 3 (range: 1–6) at T1. The
median time between T0 and T1 was 902 days (range: 363–
1,169). At T0, 20 patients received DMT (six interferon beta,
six glatiramer acetate, five dimethyl fumarate, three fingolimod),
at T1 21 PwMS received DMT (three interferon beta, six
glatiramer acetate, six dimethyl fumarate, four fingolimod, one
teriflunomide, one ocrelizumab).
Psychophysiological Stress and Relaxation
Responses
Stress exposure triggered a pronounced increase in pulse (t
= 5.25, p < 10−4) and perceived stress (t = 3.70, p =
0.0017), cessation of stress induced a substantial decrease in both
parameters (pulse: t = −5.80, p < 10−4; perceived stress, t =
−4.66, p < 10−4; Figure 2).
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FIGURE 2 | Psychophysiological stress and relaxation responses. The bar graphs depict the mean and the standard deviation of raw perceived stress ratings and
pulse rates (i.e., ratings and pulse rates not corrected for CNI) across participants separately for the respective experimental stage.
TABLE 1 | Depicts raw scores (i.e., not corrected for CNI) for all six HAQUAMS

































Lower scores indicate a higher HRQoL. Specifically, the number reported in the upper line
of each cell reports the median and the numbers in the lower line report parameter range
across all 28 PwMS.
Longitudinal Variations of HRQoL
Table 1 depicts the raw scores for the total HAQUAMS
score and the five subscales. The temporal variations of
each parameter for each PwMS and corresponding parameters
of inferential statistics, indicating a significant worsening
of overall HRQoL and social functioning, are shown in
Figure 3.
Predicting Future HRQoL Based on
Clinic-Demographic and Radiographic
Markers
To predict future HRQoL based on clinic-demographic and
radiographic markers, we tested for sex, age, education, clinical
disability, annualized relapse rate, T2-weighted lesion load,
MS type (RRMS or SPMS), disease duration, and overall GM
fraction as potential sources of interindividual variation of the
participants. Among these, only disease type (RRMS or SPMS)
was predictive of future variations in the total HAQUAMS score
(Figure 4).
Predicting Future HRQoL Based on
Neurocognitive Stress and Relaxation
Processing
This analysis identified one neural network comprising
(para-)limbic regions (i.e., anterior insula, left amygdala, and
left anterior cingulate cortex and also left fusiform gyrus and
right supplementary motor cortex) whose stress-triggered
activity variations were positively associated with future lower
limb mobility (t = −3.62, pFWE-corrected = 0.020; Figure 5).
Higher activity variations during stress cessation of a different
widespread network predicted lower overall HRQoL (t = 3.68,
pFWE = 0.008) and mood on trend level (t = 3.37, pFWE =
0.087; Figure 5). This second network included the following
areas: right superior frontal gyrus (medial segment), left superior
parietal lobule, right planum temporale, and also left inferior
occipital gyrus, right superior and middle temporal gyrus, right
fusiform gyrus, right postcentral gyrus, right planum polare, and
left posterior insula (Figure 5).
DISCUSSION
We investigated whether brain activity triggered by mild
psychological stress or by its cessation predicts the future
evolution of HRQoL in 28 PwMS.
In a first analysis, we showed that the fMRI stress task
employed induced a stress response increasing perceived stress
and pulse and that stress cessation was accompanied by
the remission of both parameters. Together, these findings
emphasize the fundamental ability of our task to induce a
psychophysiological stress response and measure relaxation
after stress.
In a second analysis, we characterized the evolution of
HRQoL across the follow-up period and revealed that overall
HRQoL and social functioning deteriorated significantly, a
Frontiers in Neurology | www.frontiersin.org 7 November 2021 | Volume 12 | Article 753107
Meyer-Arndt et al. Stress and HRQoL in MS
FIGURE 3 | Patient-specific HAQUAMS scores for overall HRQoL and five HAQUAMS subscales at T0 and T1 corrected for the CNI mentioned in the text. Each line
depicts the trajectory of the given marker for an individual participant. The t-statistics and p-values reported characterizing the effect of time on each given parameter
across all 28 PwMS. It is noted that higher scores correspond to less HRQoL, positive t-statistics to a (not necessarily significant) increase of a marker across time
(and thus to a not necessarily significant HRQoL worsening).
finding which is compatible with an inverse association of
MS disease duration and future HRQoL (18). Furthermore,
a supplementary analysis testing whether longitudinal HRQoL
variations were accompanied by similar changes in EDSS showed
a pronounced positive association for the HAQUAMS lower
limb mobility subscale and EDSS (and between EDSS and the
total HAQUAMS score on an α = 0.1 level). The associations
between EDSS and other HAQUAMS subscales were much less
pronounced. This finding underlines the importance of HRQoL
as a complementary factor in the assessment of MS and patient-
reported outcomes for treatment success.
Finally, in the key analysis of the study, we tested whether
neural network activity changes induced by exposure to or
cessation of stress (i.e., relaxation) can be harnessed to predict
the future evolution in overall HRQoL. Complementary analyses
tested the same effects for the HAQUAMS subscales. The key
analysis showed that the activity of a widely distributed network
triggered by cessation of stress (i.e., relaxation) was predictive
of overall HRQoL aggravation, and the complementary analyses
showed that activity of the same network was predictive of mood-
related HRQoL aggravation on an αFWE = 0.1 level. Specifically,
the weaker the activity decline of this network after stress (i.e.,
the less neural relaxation), the more pronounced the reduction
in overall andmood-related HRQoL. The brain regions identified
as contributing to this network could provide a clue to the nature
of the positive link between neural relaxation and mood-related
HRQoL from a cognitive neuroscience perspective. In particular,
the network comprised the medial segment of the right superior
frontal gyrus, which is located in the dorsomedial PFC (dmPFC).
Neuroimaging studies found that dmPFC activity is related
to self-referential processing during emotion regulation (48).
Moreover, depressed patients show greater activity in this area
during emotion regulation tasks than healthy controls (49), and
stronger dmPFC activity during such tasks is positively linked
to the severity of future depressive symptoms (50). Thus, given
the positive association between the activity of this network and
the right superior frontal gyrus (bar graph lower panel Figure 5),
this finding could suggest that protracted self-reference after
cessation of stress is a factor related to future mood-related
HRQoL aggravation in MS. This interpretation of an altered
relaxation processing in MS would also be consistent with the
results of our recent study showing that PwMS have difficulty
in integrating peripheral stress signals into the perception of
relaxation (51). Moreover, when additionally considering the
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FIGURE 4 | Prognostic information of established clinical, demographic, and radiographic parameters for future variations in overall HRQoL. Higher 1HAQUAMS
scores correspond to stronger longitudinal declines in HRQoL. W, Wald-statistic.
high correlation between temporal differences in mood-related
and overall HRQoL of r= 0.80 (which was the highest correlation
among all pairs of [sub-] scales; refer to Supplementary Figure 2,
right panel), these arguments might legitimately also be used to
explain the link between the activity of this network and future
aggravation in overall HRQoL because overall HRQoL assessed
by HAQUAMS is particularly sensitive to mood-related HRQoL.
In addition to these findings on associations between neural
relaxation and HRQoL, a complementary analysis showed that
stress-induced activity of a network comprising prefrontal
regions (i.e., anterior cingulate cortex [ACC], an area located in
the ventromedial prefrontal cortex; vmPFC), limbic (amygdala),
and paralimbic regions (anterior insula) was negatively linked
to future worsening of lower limb mobility scores. In other
words, the stronger the network’s stress response, the lower the
self-reported future aggravation of lower limb mobility. Two
potential explanations come into mind for this association. First,
in line with findings of our recent longitudinal study showing that
stress-induced activity of a prefronto-limbic network predicts
the future atrophy of cerebellar areas in PwMS (19), one might
assume that central stress processing directly contributes to
brain atrophy of mobility-related regions and thus to subsequent
motor impairment. Neuropathological candidate mechanisms
that could mediate this association were documented in animal
work, showing that sustained experimental stress exposition (52)
and sustained excessive glucocorticoid release (53) can provoke
loss of dendritic spines. This explanation would also be in line
with our recent crosssectional findings showing that stronger
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FIGURE 5 | Neural network activity and future HRQoL evolution. T0 activity of one network (network #23, shown in the upper row of the figure) triggered by stress
exposure (which was reflected by the difference in network activity for stress minus baseline I) was predictive of future variations in lower limb mobility. The activity of
another network (#28, shown in the lower row of the figure) triggered by cessation of stress (reflected by the differential network activity for baseline II minus stress)
was predictive of future variations in overall HRQoL (i.e., total HAQUAMS score) and mood. The left side of the figure (“I. HRQoL-predictive neural networks”) depicts
different features of the two networks. In particular, the rendered brains in the leftmost column of (I.) and the bar graphs to their right depict individual brain regions
included in the neuroanatomical atlas related to the predictive networks and the strength and direction of this relation (i.e., their component loadings; see Supplement
for details on the computation of these loadings as well as a comprehensive overview of loadings of all atlas regions). The circular network graphs on the rightmost
side of (I.) illustrate the intercorrelations of manifest regional signals for areas belonging to a given network. It is noted that the strength and direction of these
intercorrelations do not only depend on the fact that the given regions are all maximally related to the same network but also on weaker relations to other networks
and that the contribution of these other networks to the activity of regions may vary across regions. The scatter graphs on the right side of the figure (“II. Network
activity at T0 and HRQoL-changes T1–T0”) illustrates the associations between a given differential network activity marker (i.e., for stress or relaxation) and the
temporal difference score of the given HAQUAMS parameter. Positive differences 1HAQUAMS denote worsening in HRQoL ratings over time.
anterior insula stress responses are accompanied by less severe
pyramidal symptoms in PwMS (28), with vmPFC-mediated
glucocorticoid regulation found in healthy persons by Urry et al.
(54), and with findings showing that stronger cortisol awakening
responses in PwMS are associated with worse EDSS 9 months
later (16). Second, associations between central stress processing
and perceived future aggravation of lower limb mobility
might be explained by functional processes also observed in
motor functional neurological disorders. In particular, these
disorders are frequently accompanied by psychological stress
(55), are characterized by limb weakness or paralysis, functional
movement disorders (55), alterations in resting state functional
connectivity (56), and an absence of obvious structural brain
damage (55). This explanation might also be compatible with
associations between resting-state functional connectivity and
future disease worsening across a time span of 6.4 years in PwMS
observed by Rocca et al. (57). Importantly, the first and the
second explanation must not necessarily be mutually exclusive.
Instead, one might speculate that impairment in (perceived)
lower limb mobility in MS is mediated by a mixture of functional
and structural factors.
Some limitations of the present work should be mentioned.
One limitation is the lack of a control group, which impedes
evaluation of whether the observed associations are specific to
MS. However, as this study is the first to address neural predictors
of future HRQoL in MS, we consider the predictors identified
as an important foundation for further research. Another aspect
that should be mentioned is the only moderate sample size of
this task-based fMRI MS study. Thus, future studies addressing
associations between neural correlates of psychological stress
(or of other factors with neuropsychiatric importance) on one
hand and QoL on the other should rely on a larger number of
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participants to facilitate analyses with higher statistical power.
However, the fact that the brain areas contributing to HRQoL-
predictive networks identified in this study (e.g., dmPFC,
amygdala, vmPFC, anterior insula) are well in line with those
found in other studies investigating stress or stress-related factors
inMS (28, 51) or independent of MS (48–50, 54) suggests that the
statistical power of our analyses does not fundamentally question
the results obtained. Another possible limitation is confounding
variables, such as Vitamin D (58), the gut microbiome (59),
physical exercise (60), or sleep disturbances (61), which pose a
challenge to any observational MS study given the heterogeneous
set of factors considered to influence the disease. At this point,
we want to mention, however, that a significant number of
conceivable factors were considered in the key robust regression
fMRI analysis on future HRQoL prediction as CNI. Specifically,
we accounted for the T0 HAQUAMS scores of a given subscale,
the follow-up period (i.e., time between T0 and T1), and
cognitive task load (which was shown to be an inverse measure
of participants’ cognitive performance). Additionally, we tested
for possible clinico-demographic and radiographic predictors of
future HRQoL variations and consequently included disease type
(SPMS vs. RRMS) as CNI in the respective regression models.
None of the other markers tested (such as clinical disability
or education) were predictive of future changes in HRQoL.
Finally, depression was not modeled as CNI because one of the
predicted HAQUAMS subscales (“mood”) is itself considered
as a measure of depression (27). Accounting for this factor
by including alternative measures would thus presumably have
removed the target variation. Consequently, we assume that
the impact of putative nuisance factors was not very relevant.
Patients with primary progressive MS were not included in the
study as this entity has often been considered diverging from
other clinical MS courses (62, 63). Future studies evaluating
the prognostic potential of stress- and relaxation-related brain
activity should consider further socio-demographic variables
as confounding factors as Baumstarck et al. (18) showed that
occupational and marital status are related to HRQoL. A final
aspect to be discussed is that in this work only PCs with a high
rank showed specific associations to MS severity measures. This
may find fault with other authors who propose that only PCs of
low rank (i.e., explaining a lot of variation) can be meaningful
for PC regression [e.g., (64)]. However, this heuristic was already
refuted by Jolliffe (43).
In conclusion, we showed that variations in neural network
activity triggered by stress exposure and its cessation can predict
the future course of HRQoL in PwMS. Our findings underline
the relevance of unimpaired stress processing and poststress
relaxation for psychobiological well-being and thus advocate a
strengthening of stress coping skills in the treatment of MS.
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